Competitive antagonism of AMPA receptors by ligands of different classes: crystal structure of ATPO bound to the GluR2 ligand-binding core, in comparison with DNQX

Research output: Contribution to journalJournal articleResearchpeer-review

Anders Hogner, Jeremy R Greenwood, Tommy Liljefors, Marie-Louise Lunn, Jan Egebjerg, Ingrid K Larsen, Eric Gouaux, Jette Sandholm Jensen Kastrup

Ionotropic glutamate receptors (iGluRs) constitute a family of ligand-gated ion channels that are essential for mediating fast synaptic transmission in the central nervous system. This study presents a high-resolution X-ray structure of the competitive antagonist (S)-2-amino-3-[5-tert-butyl-3-(phosphonomethoxy)-4-isoxazolyl]propionic acid (ATPO) in complex with the ligand-binding core of the receptor. Comparison with the only previous structure of the ligand-binding core in complex with an antagonist, 6,7-dinitro-2,3-quinoxalinedione (DNQX) (Armstrong, N.; Gouaux, E. Neuron 2000, 28, 165-181), reveals that ATPO and DNQX stabilize an open form of the ligand-binding core by different sets of interactions. Computational techniques are used to quantify the differences between these two ligands and to map the binding site. The isoxazole moiety of ATPO acts primarily as a spacer, and other scaffolds could potentially be used. Whereas agonists induce substantial domain closures compared to the apo structure, ATPO only induces minor conformational changes. These results are consistent with the hypothesis that domain closure is related to receptor activation. To facilitate the design of novel AMPA receptor antagonists, we present a modified model of the binding site that includes key residues involved in ligand recognition.
Original languageEnglish
JournalJournal of Medicinal Chemistry
Volume46
Issue number2
Pages (from-to)214-21
Number of pages8
ISSN0022-2623
DOIs
Publication statusPublished - 16 Jan 2003

    Research areas

  • Binding Sites, Crystallography, X-Ray, Excitatory Amino Acid Antagonists, Isoxazoles, Ligands, Models, Molecular, Organophosphonates, Quinoxalines, Receptors, AMPA

ID: 44729610